CRBN-6-5-5-VHL

N/A

Report date: 2022/12/27 18:20:00
NME

Base Information

Drug NameCRBN-6-5-5-VHL
Drug Alias NameCRBN-6-5-5-VHL
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionCereblon inhibitors
TargetsCereblon
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bonn
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Bonn
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A